Key result
Review outlines the evolving risk and management of stent thrombosis in PCI.
This review provides a comprehensive overview of stent thrombosis, a potentially fatal complication of PCI, and the evolution of therapies and technologies to mitigate its risk.
Offers synthesis of stent thrombosis strategies in PCI; leaves open prospective validation of future technologies.
The percutaneous coronary intervention (PCI) has undergone rapid evolution over the last 40 years and has become one of the most widely performed medical procedures. The introduction of intracoronary stents has improved the safety and efficacy of PCI. However, with the advent of stenting, a new potentially fatal enemy has emerged: stent thrombosis. Ever since, adjunct pharmacological therapy, stent technique, and technology have been adjusted to reduce the risk of stent thrombosis. The aim of the present article is to provide an overview of the past, present, and future aspects of PCI in relation to stent thrombosis.
No takes yet. Share an insight, caveat, or question.
Kerkmeijer et al. (2018) conducted a review in Stent thrombosis. Percutaneous coronary intervention (drug-eluting stents and bioresorbable vascular scaffolds) was evaluated. This review provides an overview of the past, present, and future aspects of percutaneous coronary intervention in relation to the risk and management of stent thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: